Statistics
Publications
1
Citations
13
H-Index
1
Active since
2024
Affiliations
NewGen Therapeutics (United States)(Current)
Yin Luo is an author at NewGen Therapeutics (United States) specializing in cathepsin activity, cell biology, and glycobiology.
Publications per year
2024–2024
1
1
Heparan sulfate selectively inhibits the collagenase activity of cathepsin K
Xiaoxiao Zhang, Yin Luo, Huanmeng Hao et al. · Matrix Biology · 2024 · 13 citations · Full text
1–1 of 1